Company intelligence for public markets

Long the filing. Short the spin.

We extract key insights from regulatory filings within minutes of publication and trace every number to its source.

10-QSHOPQ3 FY2026Filed Nov 3, 2026

Total revenues grew 32% year-over-year to $3.74 billion for the three months ended September 30, 2026.
Operating income significantly improved to $568 million, up from $343 million in the prior year's comparable quarter.
Merchant solutions revenue increased by 35% year-over-year, reaching $2.91 billion, driven by Shopify Payments.

8.8 MB as filed

10-QPFEQ3 FY2026Filed Nov 3, 2026

Total revenues for Q3 2026 were $16.58 billion, relatively flat year-over-year, with a 7% operational increase excluding COVID-19 products.
Net income attributable to Pfizer Inc. common shareholders for Q3 2026 decreased to $3.24 billion ($0.56 EPS) from $3.54 billion ($0.62 EPS) in Q3 2025.
Nine-month total revenues increased to $46.07 billion from $45.02 billion year-over-year, with a 7% operational increase excluding COVID-19 products.

15 MB as filed

10-QJPMQ3 FY2026Filed Nov 3, 2026

Total net revenue increased by 8% to $50.2 billion, primarily driven by a 13% increase in net interest income.
Net income increased by 6% to $15.3 billion for the third quarter of 2026 compared to the prior year.
Noninterest expense increased by 12% to $27.3 billion, attributed to higher compensation and investments in technology and marketing.

50.6 MB as filed

10-QCPNGQ3 FY2026Filed Nov 3, 2026

Total net revenues increased by 7% to $9,962 million for the three months ended September 30, 2026, compared to $9,267 million in the prior year period.
Cost of sales increased by 13% year-over-year, partly due to a $95 million inventory loss from the Incheon fulfillment center fire.
Cash and cash equivalents, and restricted cash stood at $5.5 billion as of September 30, 2026, indicating a strong liquidity position.

5.7 MB as filed

10-QLITEQ1 FY2027Filed Nov 3, 2026

Net revenue increased by 136.5% to $1.26 billion for the quarter ended September 26, 2026, compared to $533.8 million in the prior year.
Net income increased substantially to $360.3 million, or $3.54 per diluted share, compared to $4.2 million, or $0.05 per diluted share, in the prior year.
Gross profit grew by 254.8% to $644.0 million, with gross margin expanding to 51.0% from 34.0% year-over-year.

14.3 MB as filed

01—In focus

Popular Companies

Pick one to preview its page: the latest 10-K read for you, what it filed lately, and its revenue over the years.

Last close and 1M change: from the last close a month or more earlier

Technology

AAPLApple

$331.90−0.5%1M

Oct 2close Nov 3

10-KThe FY2026 annual report, read for youfiled Nov 3, 2026

Total net sales increased by 15% to $478.8 billion in fiscal year 2026, primarily driven by a 21% surge in iPhone sales and a 13% rise in Services revenue.
The Greater China region demonstrated exceptional growth, with net sales up 28%, indicating a strong market rebound or increased demand in the area.
Research and Development expenses saw a significant increase of 32% to $45.8 billion, underscoring Apple's commitment to innovation, especially in Artificial Intelligence.